Newsfile

Search documents
Tier One Silver Updates LIFE Financing and Receives Bridge Loan
Newsfile· 2025-06-23 22:22
Group 1 - The targeted closing date for Tier One Silver Inc.'s LIFE offering has been extended to July 15, 2025 [1] - The company has secured a C$175,000 bridge loan from a director to cover Peruvian governmental mineral project concession fees due June 30, 2025 [1][2] - The bridge loan is unsecured, carries a 12% annual interest rate, and is due for repayment by September 30, 2025, or upon completion of the LIFE offering or other financing totaling at least C$1 million [1][2] Group 2 - The company aims to raise at least C$4.1 million through the issuance of units priced at $0.09, with each unit consisting of one common share and one share purchase warrant [2] - The net proceeds from the offering will be allocated for exploration of the Curibaya project, including drilling of the Cambaya target area, and for general corporate and working capital purposes [2] - The offering and bridge loan are subject to approval from the TSX Venture Exchange and customary completion conditions [2][3] Group 3 - The company may pay eligible finders a cash fee of 6% of the gross proceeds from the offering and issue finders warrants equal to 6% of the number of units sold [3] - Each finders warrant will have the same terms as the unit warrants [3] Group 4 - Tier One Silver is focused on discovering world-class silver, gold, and base metal deposits in Peru, with a management team experienced in capital raising and exploration success [5]
24/7 Market News: VENU has Partnered with Industry Leaders, including Aramark and AEG, to Scale Operations
Newsfile· 2025-06-23 13:31
24/7 Market News: VENU has Partnered with Industry Leaders, including Aramark and AEG, to Scale OperationsJune 23, 2025 9:31 AM EDT | Source: 24/7 Market NewsDenver, Colorado--(Newsfile Corp. - June 23, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that as Venu Holding Corporation (NYSE American: VENU) aggressively scales its fan-founded, premium amphitheater model across the country, its recently ann ...
Large Shareholder Questions Governance of the SPAR Group Board of Directors
Newsfile· 2025-06-23 13:18
Large Shareholder Questions Governance of the SPAR Group Board of DirectorsJune 23, 2025 9:18 AM EDT | Source: Robert G. BrownPalm Beach Gardens, Florida--(Newsfile Corp. - June 23, 2025) - SPAR Group, Inc. ("SPAR") held the 2025 Annual Shareholders' Meeting on June 12, 2025 (the "2025 Shareholder Meeting"), to, among other proposals, elect nominees to the Board. Of the 7 nominees for election to the Board, 3 of the then-serving directors nominated for reelection were not reelected.[1]Section ...
Mundoro Commences the 2025 Summer Drill Program at Borsko with BHP
Newsfile· 2025-06-23 12:21
Mundoro Commences the 2025 Summer Drill Program at Borsko with BHPJune 23, 2025 8:21 AM EDT | Source: Mundoro Capital Inc.Vancouver, British Columbia--(Newsfile Corp. - June 23, 2025) - Mundoro Capital Inc. (TSXV: MUN) (OTCQB: MUNMF) (www.mundoro.com) ("Mundoro" or the "Company") is pleased to announce the commencement of its summer drill program at the Borsko Project, part of the BHP-Mundoro option earn-in agreement in the Central Timok Magmatic Complex ("TMC") in Serbia.The Borsko Project, c ...
Glow Lifetech Provides Commercial Update; Expands to 1000+ Stores in Ontario and Achieves #2 Oil Brand with MOD
Newsfile· 2025-06-23 11:30
Core Insights - Glow Lifetech Corp. has achieved significant market momentum in Ontario, expanding its retail distribution to over 1,000 licensed stores, marking a 45% increase year-to-date and establishing itself as the 2 ranked oil brand with its MOD™ line [2][3][4] Group 1: Retail Expansion - The company has expanded its retail footprint to over 1,000 stores in Ontario, reflecting strong demand for its differentiated product portfolio [2][3] - This expansion is expected to continue, further solidifying Glow's position as a category leader in the province [2][3] Group 2: Brand Performance - Glow's flagship MOD™ brand has advanced to become the 2 ranked oil brand in Ontario, indicating a growing base of loyal consumers and successful product launches [3][4] - The sustained growth trajectory of both MOD™ and .decimal™ brands is supported by strong commercial traction and record demand [3][4] Group 3: Product Innovation - Glow launched MOD™ CBN:THC Drops in May 2025 and secured a new listing for MOD™ CBN:CBD Drops in early June, both of which have seen strong customer demand [5] - These new products tap into the rising demand for CBN-based formulations, reinforcing Glow's commitment to developing innovative cannabis products [5]
Aero Energy Completes Acquisition of Kraken Energy to Create a Premier North American Uranium Developer
Newsfile· 2025-06-23 11:30
Core Viewpoint - Aero Energy Limited has successfully completed the acquisition of Kraken Energy Corp, creating a leading North American uranium developer by combining their respective assets and strengths [1][2]. Company Overview - The merger combines Aero's 250,000-acre land package in Saskatchewan's Athabasca Basin with Kraken's high-grade uranium properties in the U.S., including the Apex Uranium Property, Nevada's largest past-producing uranium mine [12]. - The new entity aims to unlock high-grade, unconformity-style mineralization and capitalize on the growing demand for uranium [12]. Transaction Details - Under the terms of the arrangement, all issued and outstanding Kraken Shares were exchanged for a total of 57,922,329 common shares of Aero at an exchange ratio of 0.97037 Aero Shares for each Kraken Share [3]. - Following the completion of the arrangement, Aero has 179,849,606 shares issued and outstanding, with approximately 67.79% held by Aero's shareholders prior to the arrangement and 32.21% by former Kraken shareholders [3]. Leadership Changes - The board of directors of Aero post-merger consists of five members, including three existing Aero directors and two nominees from Kraken [5]. - Galen McNamara continues as CEO and Director of Aero, with Carson Halliday appointed as CFO and Corporate Secretary [5]. Regulatory Approvals - The Supreme Court of British Columbia approved the arrangement on June 17, 2025, and the shareholders of Kraken approved the transaction at their annual general and special meeting on June 11, 2025 [2][3]. Market Impact - The merger is expected to enhance the companies' ability to unlock permits and scale operations effectively, positioning them to capture momentum in the uranium market [2]. - The Kraken Shares are anticipated to be de-listed from the Canadian Securities Exchange effective June 20, 2025, and Aero plans to terminate Kraken's public reporting obligations [8].
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
Newsfile· 2025-06-23 11:30
Core Insights - Medicus Pharma Ltd. has appointed Andrew Smith as Chief Operating Officer, bringing over three decades of experience in asset management and financial operations [2][3] - The company is actively engaged in clinical development, particularly with its SKNJCT-003 Phase 2 clinical study for treating Basal Cell Carcinoma (BCC) using novel Doxorubicin Microneedle Arrays (D-MNA) [4][8] Company Leadership - Andrew Smith's previous roles include Chief Executive of SR Asset Management and Co-Head of Americas at Aberdeen Asset Management, highlighting his extensive leadership experience [2][3] - Dr. Raza Bokhari, Executive Chairman and CEO, expressed confidence in Smith's expertise as the company expands its operations across three continents [3] Clinical Development Updates - The SKNJCT-003 Phase 2 clinical study has randomized over 50 of the 90 expected patients, with a positive interim analysis showing more than 60% clinical clearance [4][8] - The study is being conducted at nine clinical sites across the United States, having commenced patient randomization in August 2024 [4] - The investigational review board has increased the participant count for SKNJCT-003 from 60 to 90 subjects, and the company is also expanding clinical trial sites in Europe [4] Additional Clinical Studies - Medicus Pharma is conducting another clinical study, SKNJCT-004, in the United Arab Emirates, which aims to randomize 36 patients across four sites [5] - The principal investigator for the UAE study is Cleveland Clinic Abu Dhabi, with coordination by Insights Research Organization and Solutions [5] Acquisition Plans - The company has entered into a binding letter of intent to acquire Antev Ltd., a UK-based biotech company developing Teverelix for advanced prostate cancer patients [6][9] - The acquisition is subject to due diligence, negotiation of definitive agreements, and regulatory approvals [9]
Prospector Begins Maiden Drill Program on ML Project, Yukon
Newsfile· 2025-06-23 11:30
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2025) - Prospector Metals Corp. (TSXV: PPP) (OTCQB: PMCOF) (FSE: 1ET0) ("Prospector" or the "Company") is pleased to announce that it has commenced drilling on its flagship ML Project in the Yukon ("ML"). The fully funded program will include up to 5000m of diamond drilling over a 10-week period through to the end of August to test high-priority target areas identified during the Company's 2024 exploration program and at the undrilled Bueno Target. Hi ...
Great Pacific Gold Enters into Arrangement Agreement for 1:1 Spin Out of Walhalla
Newsfile· 2025-06-23 11:30
Great Pacific Gold Enters into Arrangement Agreement for 1:1 Spin Out of WalhallaReceives $1.5 Million Cash PaymentJune 23, 2025 7:30 AM EDT | Source: Great Pacific Gold Corp.Vancouver, British Columbia--(Newsfile Corp. - June 23, 2025) - Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) ("Great Pacific", "GPAC" or the "Company") is pleased to provide an update on the previously announced spin out (the "Spin Out") whereby Great Pacific will distribute the shares of a new company ...
Nebius Accelerates Next Generation of Healthcare and Life Sciences Innovation with Inaugural AI Discovery Awards
Newsfile· 2025-06-23 11:01
Nebius Accelerates Next Generation of Healthcare and Life Sciences Innovation with Inaugural AI Discovery AwardsJune 23, 2025 7:01 AM EDT | Source: NebiusFull-stack AI infrastructure provider backs pioneering companies in biotech, drug discovery, genomics and multiomics, and healthcare diagnostics with GPU cloud and inferencing credits totalling over $850,000.Amsterdam, Netherlands--(Newsfile Corp. - June 23, 2025) - Nebius (NASDAQ: NBIS) has named the winners of its inaugural AI Discovery Awa ...